Peter E Fecci

researcher

Peter E Fecci is …
instance of (P31):
humanQ5

External links are
P496ORCID iD0000-0002-2912-8695

P108employerDuke UniversityQ168751
P735given namePeterQ2793400
PeterQ2793400
P106occupationresearcherQ1650915
P21sex or gendermaleQ6581097

Reverse relations

author (P50)
Q34120472Antibody-based immunotherapy for malignant glioma
Q90986207Antigen-loaded monocyte administration induces potent therapeutic antitumor T cell responses
Q28083907Are BiTEs the "missing link" in cancer therapy?
Q91736550Brain immunology and immunotherapy in brain tumours
Q89573873CAR T cells and checkpoint inhibition for the treatment of glioblastoma
Q90326760CD27 stimulation unveils the efficacy of linked class I/II peptide vaccines in poorly immunogenic tumors by orchestrating a coordinated CD4/CD8 T cell response
Q48248131Editorial: Turning fluorescence into black and white
Q38953017Embracing rejection: Immunologic trends in brain metastasis
Q50056454Enhancing Radiation Therapy Through Cherenkov Light-Activated Phototherapy.
Q35114086Immunotherapy for malignant glioma
Q42149055Increased expression of programmed death ligand 1 (PD-L1) in human pituitary tumors
Q112296925Preclinical Modeling of Surgery and Steroid Therapy for Glioblastoma Reveals Changes in Immunophenotype that are Associated with Tumor Growth and Outcome
Q43051467Reversal of warfarin associated coagulopathy with 4-factor prothrombin complex concentrate in traumatic brain injury and intracranial hemorrhage
Q47156351Single fraction stereotactic radiosurgery for multiple brain metastases
Q97540672The intersection between immunotherapy and laser interstitial thermal therapy: a multipronged future of neuro-oncology
Q93371746Upfront Magnetic Resonance Imaging-Guided Stereotactic Laser-Ablation in Newly Diagnosed Glioblastoma: A Multicenter Review of Survival Outcomes Compared to a Matched Cohort of Biopsy-Only Patients

Search more.